Therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder

Abstract

The object is to provide a therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder, more particularly, a therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder derived from spinal cord injury. A keratan sulfate oligosaccharide or a derivative thereof was found to have an effect of improving the traumatic neural disease (disorder) and/or motor function disorder derived from spinal cord injury and to be useful as the therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder. That is, according to the present invention, there is provided a therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder comprising an effective amount of the keratan sulfate oligosaccharide or the derivative thereof.

Dependencies are inferred from the claim text.